Compound information
- Natural Products
- ZC2027889
- Molecular Formula
- C25H27N3O5
- Molecular Weight
- 449.195070964 g/mol
- Structure
-
- IUPAC Name
- benzyl (2S)-2-[[(1S)-1-(1H-indol-3-ylmethyl)-2-methoxy-2-oxo-ethyl]carbamoyl]pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C25H27N3O5/c1-32-24(30)21(14-18-15-26-20-11-6-5-10-19(18)20)27-23(29)22-12-7-13-28(22)25(31)33-16-17-8-3-2-4-9-17/h2-6,8-11,15,21-22,26H,7,12-14,16H2,1H3,(H,27,29)/t21-,22-/m0/s1
- InChI Key
- ZOHDHRBXTKVWCS-VXKWHMMOSA-N
- SMILES
- COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1
- Source
- ZINC000012366842
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 33 | Ring Count | 4 |
| Heteroatom Count | 8 | Rotatable Bond Count | 7 |
| Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
| Topological Polar Surface Area | 100.73 Å2 | LogP | 3.591 |
| LogS | -5.271 | LogD | 3.732 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.242 | Pgp substrate | 0.668 |
| HIA | 0.967 | F20 % | 0.986 |
| F30 % | 0.116 | Caco-2 | -4.812 |
| MDCK | -5.267 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.001 | PPB | 98.452 |
| VD | 2.181 | Fu | 1.704 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.053 | CYP1A2 substrate | 0.641 |
| CYP2A6 substrate | 0.44 | CYP2B6 substrate | 0.561 |
| CYP2C19 inhibitor | 0.824 | CYP2C19 substrate | 0.926 |
| CYP2C8 substrate | 0.807 | CYP2C9 inhibitor | 0.427 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.012 |
| CYP2D6 substrate | 0.929 | CYP2E1 substrate | 0.163 |
| CYP3A4 inhibitor | 0.399 | CYP3A4 substrate | 1.0 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.603 | CL | 4.2 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.098 | Hepatotoxicity | 0.516 |
| Mutagenicity | 0.006 | Rat Oral Acute Toxicity | 0.539 |
| FDAMDD | 0.955 | Skin Sensitization | 0.0 |
| Carcinogenicity | 0.002 | Eye Corrosion | 0.008 |
| Eye Irritation | 0.002 | Respiratory Toxicity | 0.031 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.572 | IGC50 | 3.896 |
| LC50FM | -1.805 | LC50DM | 3.366 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.355 | NR-AR-LBD | 0.314 |
| NR-AhR | 0.877 | NR-Aromatase | 0.21 |
| NR-ER | 0.291 | NR-ER-LBD | 0.449 |
| NR-PPAR-gamma | 0.397 | SR-ARE | 0.19 |
| SR-ATAD5 | 0.673 | SR-HSE | 0.398 |
| SR-MMP | 0.683 | SR-p53 | 0.382 |
Similar covalent drugs
No similar covalent drugs found for this compound.